It has long been known that anemia increases the risk of death and complications in patients who have cardiovascular surgery, but results of a new study show that these risks are increased in patients with anemia who undergo various types of surgery, including gynecological procedures.
It has long been known that anemia increases the risk of death and complications in patients who have cardiovascular surgery, but results of a new study show that these risks are increased in patients with anemia who undergo various types of surgery, including gynecological procedures.1
Compared with patients without anemia, the risk of death within 30 days after surgery was 42% higher among patients with anemia. In addition, patients with anemia were 35% more likely to experience cardiac, respiratory, urinary, and wound complications as well as sepsis and blood clots.
“Because even mild anemia increases the risk of postoperative morbidity and mortality in patients undergoing major non-cardiac surgery, doctors need to consider preoperative treatment of anemia when possible. Further research is needed to establish the efficacy, safety, and cost-effectiveness of such preoperative anemia management,” the study authors conclude.
Related Content
Educational Tutorial: Anemia in PregnancyCan Massive Blood Loss Be Predicted in Women With Placenta Accreta?
Reference
1. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396-1407.
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More